Proposes a structural constraint on AI capacity routes to enhance eligibility selection, emphasizing governance.
Organizations that buy artificial-intelligence capacity increasingly choose among heterogeneous routes to the same outcome: hosted model interfaces, private inference, rented accelerator time, tool and retrieval services, and local execution. The machinery that compares those routes is, by construction, an optimizer: it ranks candidates by cost, latency, capability, and availability. This paper proposes a structural constraint on that machinery. A governed AI-capacity exchange must determine whether a route is eligible before economics or performance may rank it, and optimization may operate only inside the eligible set; it cannot create, widen, or revive authority. The paper develops this proposal as the ARBITER policy boundary within the SkipJack Cognitive Exchange: a minimum authority contract covering identity and delegation, the workload envelope, eligibility evaluation over typed constraint families, bounded grant issuance, a typed grant lifecycle with explicit revocation and stale-state semantics, fail-closed defect handling, and queryable decision-basis evidence. The paper also states the strongest opposing position fairly: existing identity, access-management, policy, contract, and orchestration controls may already preserve every decision-relevant authority fact at lower cost, and the proposed contract loses for a bounded use case unless it changes an eligibility decision, prevents authority widening, preserves a material audit fact, exposes stale or contradictory state, or makes a falsifiable handoff safer. The paper claims no novelty, adoption, market demand, legal sufficiency, customer value, production behavior, or measured performance. All system behavior described is proposed and unobserved; the later simulated use case is synthetic and carries no evidentiary weight.
No takes yet. Share an insight, caveat, or question.
Justin H. Kuiper (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: